Gus Khursigara
About Gus Khursigara
Gus Khursigara serves as the Vice President of Medical Affairs and Clinical Strategy at Inozyme Pharma, where he has worked since 2019. He has extensive experience in the pharmaceutical industry, having held various leadership roles at Alexion Pharmaceuticals and other companies.
Current Role at Inozyme Pharma
Gus Khursigara serves as the Vice President of Medical Affairs and Clinical Strategy at Inozyme Pharma. He has held this position since 2019, contributing to the company's strategic direction in medical affairs. His role involves overseeing clinical strategies and ensuring that medical communications align with the company's objectives in Boston, Massachusetts.
Previous Experience in Pharmaceutical Industry
Before joining Inozyme Pharma, Gus Khursigara held various significant roles in the pharmaceutical industry. He worked at Alexion Pharmaceuticals, Inc. in multiple capacities, including Executive Director of Global Medical Affairs from 2010 to 2015 and Vice President, Global Medical Affairs Lead for Neurology from 2017 to 2018. He also served as Senior Director of Global Scientific Communications for PNH from 2007 to 2010. His experience spans over a decade in medical affairs and scientific communications.
Educational Background
Gus Khursigara has a robust educational background in the life sciences. He earned a Doctor of Philosophy (PhD) in Neurobiology and Neurosciences from Joan & Sanford I. Weill Medical College of Cornell University between 1995 and 2000. Prior to that, he obtained a Master of Science (MS) in Physiology and Neurobiology from the University of Connecticut from 1993 to 1995. His foundational studies include a Bachelor's degree in Biochemistry and Cellular Biology from the University of California San Diego, completed from 1986 to 1991.
Career Progression at Alexion Pharmaceuticals
Gus Khursigara's career at Alexion Pharmaceuticals is marked by a series of progressive roles. He began as Associate Director of Business Development from 2003 to 2005, followed by Director of US Scientific and Medical Affairs from 2005 to 2006. He then transitioned to Director of Global Medical Information from 2006 to 2007, before taking on the role of Head of Medical for Canada from 2015 to 2016. His final role at Alexion was as Vice President, Global Medical Affairs Lead for Neurology from 2017 to 2018.